Human papillomavirus infection among human immunodeficiency virus-infected women in Maharashtra, India

Vaccine

Volumn 32, Issue 9, 2014, Pages 1079-1085

  Joshi, S ^a,c   Babu, J M ^b   Jayalakshmi, D ^b   Kulkarni, V ^c   Divate, U ^a   Muwonge, R ^d   Gheit, T ^d   Tommasino, M ^d   Sankaranarayanan, R ^d   Pillai, M R ^b  

^a JEHANGIR HOSPITAL   (India)

^b RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

^c Amrita Clinic   (India)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia (CIN); Control; Human immunodeficiency virus (HIV); Human papillomavirus (HPV); Prevention; Screening

Indexed keywords

CERVICAL CANCER; CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN); CONTROL; HUMAN IMMUNODEFICIENCY VIRUS (HIV); HUMAN PAPILLOMAVIRUS (HPV); PREVENTION; SCREENING;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HIV INFECTIONS; HUMANS; INDIA; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84895062918     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.12.060     Document Type: Article

References (52)

1. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., Shah K.V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55:244-265.
2. Munoz N., Bosch F.X., de Sanjose S., Tafur L., Izarzugaza I., Gili M., et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992, 52:743-749.
3. Schiffman M.H., Bauer H.M., Hoover R.N., Glass A.G., Cadell D.M., Rush B.B., et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993, 85:958-964.
4. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
5. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F. A review of human carcinogens: Part B. Biological agents. Lancet Oncol 2009, 10:321-322.
6. Strickler H.D., Burk R.D., Fazzari M., Anastos K., Minkoff H., Massad L.S., et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005, 97:577-586.
7. Palefsky J.M., Holly E.A. Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr 2003, 41-46. [chapter 6].
8. Ahdieh L., Klein R.S., Burk R., Cu-Uvin S., Schuman P., Duerr A., et al. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 2001, 184:682-690.
9. Minkoff H., Feldman J., De Hovitz J., Landesman S., Burk R. A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol 1998, 178:982-986.
10. Moscicki A.B., Ellenberg J.H., Farhat S., Xu J. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect Dis 2004, 190:37-45.
11. Chaturvedi A.K., Dumestre J., Gaffga A.M., Mire K.M., Clark R.A., Braly P.S., et al. Prevalence of human papillomavirus genotypes in women from three clinical settings. J Med Virol 2005, 75:105-113.
12. De Vuyst H., Steyaert S., Van Renterghem L., Claeys P., Muchiri L., Sitati S., et al. Distribution of human papillomavirus in a family planning population in Nairobi, Kenya. Sex Transm Dis 2003, 30:137-142.
13. Palefsky J.M., Minkoff H., Kalish L.A., Levine A., Sacks H.S., Garcia P., et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999, 91:226-236.
14. Sun X.W., Kuhn L., Ellerbrock T.V., Chiasson M.A., Bush T.J., Wright T.C. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997, 337:1343-1349.
15. Ellerbrock T.V., Chiasson M.A., Bush T.J., Sun X.W., Sawo D., Brudney K., et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000, 283:1031-1037.
16. Hawes S.E., Critchlow C.W., Faye Niang M.A., Diouf M.B., Diop A., Toure P., et al. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis 2003, 188:555-563.
17. La Ruche G., You B., Mensah-Ado I., Bergeron C., Montcho C., Ramon R., et al. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. Int J Cancer 1998, 76:480-486.
18. Joshi S., Sankaranarayanan R., Muwonge R., Kulkarni V., Somanathan T., Divate U. Screening of cervical neoplasia in HIV-infected women in India. AIDS 2013, 27:607-615.
19. Sankaranarayanan R., Wesley R. A practical manual on visual screening for cervical neoplasia. IARC technical publication no. 41 2003, IARC Press, Lyon.
20. Sellors J.W., Sankaranarayanan R. Colposcopy and treatment of cervical intraepithelial neoplasia: a beginners' manual 2003, International Agency for Research on Cancer, Lyon.
21. Gheit T., Landi S., Gemignani F., Snijders P.J., Vaccarella S., Franceschi S., et al. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol 2006, 44:2025-2031.
22. Schmitt M., Bravo I.G., Snijders P.J., Gissmann L., Pawlita M., Waterboer T. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 2006, 44:504-512.
23. Schmitt M., Dondog B., Waterboer T., Pawlita M., Tommasino M., Gheit T. Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. J Clin Microbiol 2010, 48:143-149.
24. Bollen L.J., Chuachoowong R., Kilmarx P.H., Mock P.A., Culnane M., Skunodom N., et al. Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization. Sex Transm Dis 2006, 33:259-264.
25. Coelho Lima B.M., Golub J.E., Tonani Mattos A., Freitas L.B., Cruz Spano L., Espinosa Miranda A. Human papillomavirus in women with and without HIV-1 infection attending an STI clinic in Vitoria, Brazil. J Int Assoc Physicians AIDS Care (Chic) 2009, 8:286-290.
26. Didelot-Rousseau M.N., Nagot N., Costes-Martineau V., Valles X., Ouedraogo A., Konate I., et al. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer 2006, 95:355-362.
27. Hernandez B.Y., Vu Nguyen T. Cervical human papillomavirus infection among female sex workers in southern Vietnam. Infect Agent Cancer 2008, 3:7.
28. Kitchener H., Nelson L., Adams J., Mesher D., Sasieni P., Cubie H., et al. Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women. Int J Cancer 2007, 121:2484-2491.
29. Luque A.E., Jabeen M., Messing S., Lane C.A., Demeter L.M., Rose R.C., et al. Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York. J Infect Dis 2006, 194:428-434.
30. Melgaco F.G., Rosa M.L., Augusto E.F., Haimuri J.G., Jacintho C., Santos L.S., et al. Human papillomavirus genotypes distribution in cervical samples from women living with human immunodeficiency virus. Arch Gynecol Obstet 2011, 283:809-817.
31. Moodley J.R., Constant D., Hoffman M., Salimo A., Allan B., Rybicki E., et al. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study. BMC Cancer 2009, 9:275.
32. Parham G.P., Sahasrabuddhe V.V., Mwanahamuntu M.H., Shepherd B.E., Hicks M.L., Stringer E.M., et al. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 2006, 103:1017-1022.
33. Singh D.K., Anastos K., Hoover D.R., Burk R.D., Shi Q., Ngendahayo L., et al. Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women. J Infect Dis 2009, 199:1851-1861.
34. Tornesello M.L., Duraturo M.L., Giorgi-Rossi P., Sansone M., Piccoli R., Buonaguro L., et al. Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women. J Gen Virol 2008, 89:1380-1389.
35. Joshi S.N., Gopalkrishna V., Kumar B.K., Dutta S., Nyaynirgune P., Thakar M., et al. Cervical squamous intra-epithelial changes and human papillomavirus infection in women infected with human immunodeficiency virus in Pune, India. J Med Virol 2005, 76:470-475.
36. Peedicayil A., Thiyagarajan K., Gnanamony M., Pulimood S.A., Jeyaseelan V., Kannangai R., et al. Prevalence and risk factors for human papillomavirus and cervical intraepithelial neoplasia among HIV-positive women at a tertiary level hospital in India. J Low Genit Tract Dis 2009, 13:159-164.
37. Sahasrabuddhe V.V., Bhosale R.A., Joshi S.N., Kavatkar A.N., Nagwanshi C.A., Kelkar R.S., et al. Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India. PLoS ONE 2010, 5:e8634.
38. Theiler R.N., Farr S.L., Karon J.M., Paramsothy P., Viscidi R., Duerr A., et al. High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Obstet Gynecol 2010, 115:1150-1158.
39. Clifford G.M., Gallus S., Herrero R., Munoz N., Snijders P.J., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005, 366:991-998.
40. Franceschi S., Rajkumar R., Snijders P.J., Arslan A., Mahe C., Plummer M., et al. Papillomavirus infection in rural women in southern India. Br J Cancer 2005, 92:601-606.
41. Bhatla N., Lal N., Bao Y.P., Ng T., Qiao Y.L. A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination. Vaccine 2008, 26:2811-2817.
42. Deodhar K., Gheit T., Vaccarella S., Romao C.C., Tenet V., Nene B.M., et al. Prevalence of human papillomavirus types in cervical lesions from women in rural Western India. J Med Virol 2012, 84:1054-1060.
43. Clifford G.M., Goncalves M.A., Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006, 20:2337-2344.
44. Luque A.E., Hitti J., Mwachari C., Lane C., Messing S., Cohn S.E., et al. Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women's HIV Interdisciplinary Network (WHIN). Int J Infect Dis 2010, 14:e810-e814.
45. Aggarwal R., Sachdeva R.K., Naru J., Suri V., Sharma A., Nijhawan R. HPV genotyping in north Indian women infected with HIV. Int J Gynecol Pathol 2012, 31:475-481.
46. Mane A., Nirmalkar A., Risbud A.R., Vermund S.H., Mehendale S.M., Sahasrabuddhe V.V. HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India. PLoS ONE 2012, 7:e38731.
47. Guan P., Howell-Jones R., Li N., Bruni L., de Sanjose S., Franceschi S., et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 2012, 131:2349-2359.
48. Levi J.E., Kleter B., Quint W.G., Fink M.C., Canto C.L., Matsubara R., et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002, 40:3341-3345.
49. Paavonen J., Jenkins D., Bosch F.X., Naud P., Salmeron J., Wheeler C.M., et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007, 369:2161-2170.
50. Paavonen J., Naud P., Salmeron J., Wheeler C.M., Chow S.N., Apter D., et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009, 374:301-314.
51. Brown D.R., Kjaer S.K., Sigurdsson K., Iversen O.E., Hernandez-Avila M., Wheeler C.M., et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis 2009, 199:926-935.
52. Houlihan C.F., Larke N.L., Watson-Jones D., Smith-McCune K.K., Shiboski S., Gravitt P.E., et al. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS 2012, 26:2211-2222.